{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T19:56:19Z","timestamp":1775937379723,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Nuclear Medicine"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1053\/j.semnuclmed.2004.11.005","type":"journal-article","created":{"date-parts":[[2005,3,12]],"date-time":"2005-03-12T12:04:54Z","timestamp":1110629094000},"page":"135-142","source":"Crossref","is-referenced-by-count":182,"title":["Positron emission tomography and bone metastases"],"prefix":"10.1053","volume":"35","author":[{"given":"Ignac","family":"Fogelman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Cook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ora","family":"Israel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Van der Wall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.semnuclmed.2004.11.005_bib1","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1136\/bmj.328.7447.1051","article-title":"Reliability of symptoms to determine use of bone scans to identify bone metastases in lung cancer","volume":"328","author":"Hetzel","year":"2004","journal-title":"BMJ"},{"key":"10.1053\/j.semnuclmed.2004.11.005_bib2","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1007\/s00259-004-1492-2","article-title":"Omission of bone scanning according to staging guidelines leads to futile therapy in non-small cell lung cancer","volume":"31","author":"Schirrmeister","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2004.11.005_bib3","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1093\/rheumatology\/35.12.1269","article-title":"The value of SPECT scans in identifying back pain likely to benefit from facet joint injection","volume":"35","author":"Dolan","year":"1996","journal-title":"Br J Rheumatol"},{"key":"10.1053\/j.semnuclmed.2004.11.005_bib4","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1148\/radiology.182.3.1531544","article-title":"Chronic low back pain","volume":"182","author":"Ryan","year":"1992","journal-title":"Radiology"},{"key":"10.1053\/j.semnuclmed.2004.11.005_bib5","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1002\/jbmr.5650071213","article-title":"Osteoporosis and chronic back pain","volume":"7","author":"Ryan","year":"1992","journal-title":"J Bone Miner Res"},{"key":"10.1053\/j.semnuclmed.2004.11.005_bib6","first-page":"1800","article-title":"Prospective evaluation of the clinical value of planar bone scans, SPECT, and (18)F-labeled NaF PET in newly diagnosed lung cancer","volume":"42","author":"Schirrmeister","year":"2001","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2004.11.005_bib7","first-page":"27","article-title":"Bone scintigraphy and the added value of SPECT (single photon emission tomography) in detecting skeletal lesions","volume":"45","author":"Savelli","year":"2001","journal-title":"Q J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2004.11.005_bib8","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1053\/snuc.2001.23527","article-title":"The role of nuclear medicine in monitoring treatment in skeletal malignancy","volume":"31","author":"Cook","year":"2001","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2004.11.005_bib9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00003072-199901000-00004","article-title":"Bone metabolic markers in the evaluation of bone scan flare phenomenon in bone metastases of breast cancer","volume":"24","author":"Koizumi","year":"1999","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2004.11.005_bib10","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1053\/snuc.2001.18742","article-title":"Quantitative studies of bone with the use of 18F-fluoride and 99mTc-methylene diphosphonate","volume":"31","author":"Blake","year":"2001","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2004.11.005_bib11","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/BF00252034","article-title":"Skeletal uptake of diphosphonate","volume":"5","author":"Fogelman","year":"1980","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2004.11.005_bib12","first-page":"1623","article-title":"Sensitivity in detecting osseous lesions depends on anatomic localization","volume":"40","author":"Schirrmeister","year":"1999","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2004.11.005_bib13","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1359\/jbmr.2003.18.12.2206","article-title":"F-18 NaF PET for detection of bone metastases in lung cancer","volume":"18","author":"Hetzel","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1053\/j.semnuclmed.2004.11.005_bib14","first-page":"272","article-title":"Assessment of malignant skeletal disease","volume":"45","author":"Even-Sapir","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2004.11.005_bib15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1095-0397(00)00042-X","article-title":"The place of whole-body PET FDG for the diagnosis of distant recurrence of breast cancer","volume":"3","author":"Lonneux","year":"2000","journal-title":"Clin Positron Imaging"},{"key":"10.1053\/j.semnuclmed.2004.11.005_bib16","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/00006231-200108000-00005","article-title":"Whole body PET for the evaluation of bony metastases in patients with breast cancer","volume":"22","author":"Ohta","year":"2001","journal-title":"Nucl Med Commun"},{"key":"10.1053\/j.semnuclmed.2004.11.005_bib17","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00432-002-0342-5","article-title":"Comparing whole body (18)F-2-deoxyglucose positron emission tomography and technetium-99m methylene diphosphonate bone scan to detect bone metastases in patients with breast cancer","volume":"128","author":"Yang","year":"2002","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2004.11.005_bib18","first-page":"431","article-title":"Accuracy of whole-body fluorine-18-FDG PET for the detection of recurrent or metastatic breast carcinoma","volume":"39","author":"Moon","year":"1998","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2004.11.005_bib19","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/01.RLI.0000063983.86229.f2","article-title":"F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma","volume":"38","author":"Gallowitsch","year":"2003","journal-title":"Invest Radiol"},{"key":"10.1053\/j.semnuclmed.2004.11.005_bib20","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1200\/JCO.1998.16.10.3375","article-title":"Detection of bone metastases in breast cancer by 18FDG PET","volume":"16","author":"Cook","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2004.11.005_bib21","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1007\/s00259-003-1370-3","article-title":"99mTc-MDP bone scintigraphy and 18F-FDG positron emission tomography in lung and prostate cancer patients","volume":"30","author":"Garcia","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2004.11.005_bib22","first-page":"1625","article-title":"Fluorodeoxyglucose uptake in human cancer cell lines is increased by hypoxia","volume":"36","author":"Clavo","year":"1995","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2004.11.005_bib23","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S1076-6332(03)80461-0","article-title":"Use of serial FDG PET to measure the response of bone-dominant breast cancer to therapy","volume":"9","author":"Stafford","year":"2002","journal-title":"Acad Radiol"},{"key":"10.1053\/j.semnuclmed.2004.11.005_bib24","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1200\/JCO.2001.19.11.2797","article-title":"Metabolic flare","volume":"19","author":"Mortimer","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2004.11.005_bib25","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/0969-8051(96)00044-3","article-title":"Detection of bony metastases of androgen-independent prostate cancer by PET-FDG","volume":"23","author":"Yeh","year":"1996","journal-title":"Nucl Med Biol"},{"key":"10.1053\/j.semnuclmed.2004.11.005_bib26","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1148\/radiology.199.3.8638000","article-title":"Metastatic prostate cancer","volume":"199","author":"Shreve","year":"1996","journal-title":"Radiology"},{"key":"10.1053\/j.semnuclmed.2004.11.005_bib27","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0090-4295(02)01509-1","article-title":"Fluorinated deoxyglucose positron emission tomography imaging in progressive metastatic prostate cancer","volume":"59","author":"Morris","year":"2002","journal-title":"Urology"},{"key":"10.1053\/j.semnuclmed.2004.11.005_bib28","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1148\/radiology.212.3.r99se21803","article-title":"Staging non-small cell lung cancer with whole-body PET","volume":"212","author":"Marom","year":"1999","journal-title":"Radiology"},{"key":"10.1053\/j.semnuclmed.2004.11.005_bib29","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1095-0397(00)00048-0","article-title":"Comparison of FDG-PET and bone scans for detecting skeletal metastases in patients with non-small cell lung cancer","volume":"3","author":"Durski","year":"2000","journal-title":"Clin Positron Imaging"},{"key":"10.1053\/j.semnuclmed.2004.11.005_bib30","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1007\/s002590050291","article-title":"Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer","volume":"25","author":"Bury","year":"1998","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2004.11.005_bib31","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S1536-1632(03)00036-2","article-title":"Comparison of bone and 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in the evaluation of bony metastases in lung cancer","volume":"5","author":"Gayed","year":"2003","journal-title":"Mol Imaging Biol"},{"key":"10.1053\/j.semnuclmed.2004.11.005_bib32","first-page":"279","article-title":"Malignant involvement of the spine","volume":"45","author":"Metser","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2004.11.005_bib33","first-page":"1407","article-title":"FDG PET can replace bone scintigraphy in primary staging of malignant lymphoma","volume":"40","author":"Moog","year":"1999","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2004.11.005_bib34","first-page":"1457","article-title":"Whole-body (18)F-FDG PET identifies high-risk myeloma","volume":"43","author":"Durie","year":"2002","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2004.11.005_bib35","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00259-001-0711-3","article-title":"Initial results in the assessment of multiple myeloma using 18F-FDG PET","volume":"29","author":"Schirrmeister","year":"2002","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2004.11.005_bib36","first-page":"79P","article-title":"PET\/CT assessment of bone metastases\u2014FDG avidity and CT patterns before and after treatment","volume":"45","author":"Israel","year":"2004","journal-title":"J Nucl Med"}],"container-title":["Seminars in Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299804000777?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299804000777?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,27]],"date-time":"2019-01-27T22:56:20Z","timestamp":1548629780000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001299804000777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["S0001299804000777"],"URL":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2004.11.005","relation":{},"ISSN":["0001-2998"],"issn-type":[{"value":"0001-2998","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]}}}